[3P] 63 Depressive and Bipolar disorders

[3P-261] Plasma Phosphoethanolamine Levels as a Biomarker for Monitoring Major Depressive Disorder

*Noriyuki Kawamura¹, Akinori Nakata², Tsuyoto Harada¹, Yoshiaki Ohashi³, Hajime Sato³, kazunori Sasaki³, Teruhiko Higuchi⁴ (1. Kawamura Clinic for General Practice, Gyouki-Kai Medical Corporation, Tokyo, Japan, 2. Graduate School of Public Health, International University of Health and Welfare, Tokyo, Japan, 3. Human Metabolome Technologies, Yamagata, Japan, 4. Japan Depression Center, Tokyo, Japan)

Keywords:MDD biomarker, Monitoring Biomarker, Plasma Phosphoethanolamine (PEA) Levels